Feed CDW
CD

CDW

CDW · NASDAQ

$146.19 -2.02% (-$3.01)
1M +8.75%
Market Cap $19.1B
P/E Ratio 17.64x
Div. Yield 1.69%
ROE 42.60%

Bulios Fair Price

$116.59

20.2% downside

Current Price

$146.19

Undervalued Fair Value Overvalued

According to Bulios Fair Price, CDW is currently overvalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Moderate
6/9
Valuation
97 /100
Cheap
P/E 17.64x
EV/EBITDA 13.51x
P/FCF 17.19x
Growth
17 /100
Declining
EPS growth 0.25%
Rev. growth 1.89%
Book val. growth 17.58%
Profitability
18 /100
Weak
Gross margin 21.36%
Net margin 4.60%
FCF margin 4.72%
Quality
74 /100
Excellent
ROIC 12.55%
ROE 42.60%
Asset turnover 1.36x
Debt
34 /100
Moderate
Debt/Equity 2.44x
Current ratio 1.17x
Net debt/EBITDA 3.07x
Stability
100 /100
Stable
Beta 0.94x
Rev. volatility 8.39%
Profitable years 6

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about CDW
Online

About the company

Universe Pharmaceuticals, Inc. is a pharmaceutical company. The firm is focused on the manufacturing, marketing, sales, and distribution of traditional Chinese medicine derivative products. It also sells biomedical drugs, medical instruments, traditional Chinese medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. The company was founded on March 2, 1998 and is headquartered in Ji'an, China.

Sector

Technology

Industry

Information Technology Services

CEO

Christine A. Leahy

Employees

14,800

Headquarters

Vernon Hills

Upcoming events

03 NOV

Earnings

Upcoming earnings report

46d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.